Skip to main
    MedSkin Solutions Dr. Suwelack
    • MedCare
    • SkinCare
    • About Us
    • News
    • Brands
    • Careers
    Contact
    • MedCare
      • Work with us
      • MedCare Applications
      • Soft Tissue Regeneration
      • Strong Tissue Regeneration
      • Speciality Products
      • Hard Tissue Regeneration
    • SkinCare
      • Work with Us
      • SkinCare Needs
      • Products
      • FAQs
    • About Us
    • News
    • Brands
    • Careers
    • Contact
    •  

    News

    Click on the articles below for updates at MedSkin Solutions Dr. Suwelack

    reveel @ ISPA, Las Vegas

    Tuesday, May 10, 2022

    Our new distribution partner, Universal Companies, successfully launched our brand reveel by MedSkin Solutions on the American market last week at the ISPA in Las Vegas.

    New In: Active Resveratrol Concentrate

    Wednesday, April 6, 2022

    Explore our new Active Resveratrol Concentrate - a powerful night concentrate to protect the skin against premature aging and to strengthen the skin’s antioxidative defense system.

    MDS 2021 – what a year!

    Monday, January 17, 2022

    Although 2021 has been challenging at times we would like to take the opportunity to celebrate the successes of our team at MedSkin Solutions Dr. Suwelack!

    Resveratrol Study

    Tuesday, November 16, 2021

    In our Resveratrol Study, we evaluated the effect of MedSkin’s resveratrol containing emulsion on aging related alterations to the skin. Assess the effect on skin elasticity, skin barrier function, skin smoothness, wrinkles, skin redness and skin density.

    India Liaison Office Opening

    Tuesday, September 7, 2021

    On September 1st 2021 we opened our India Liaison Office! Situated in Gurgaon near New Delhi this office opening is a tremendous milestone in our ambitions growth plans in India and is our 5th global office location at MedSkin Solutions Dr. Suwelack AG.

    SkinTERM Consortium

    Tuesday, April 6, 2021

    The SkinTERM project is a collaboration of 5 companies and 6 universities from seven different countries that will guide 12 PhD candidates in order to create a new generation of entrepreneurial, multidisciplinary and intersectorially trained scientists.

    MatriDerm FDA Clearance

    Monday, March 29, 2021

    In January 2021 the FDA cleared our dermal matrix MatriDerm® for use in the management of full thickness and partial thickness wounds. MatriDerm® is our single use three-dimensional acellular dermal matrix that is comprised of our native bovine collagen and bovine elastin.

    pH Value Study

    Thursday, March 25, 2021

    Acidification of the Skin and Maintenance of the Physiological Skin pH Value by Buffered Skin Care Products Formulated around pH 4

    MedSkin Solutions Dr. Suwelack AGJosef-Suwelack-Strasse 248727 BillerbeckGermany
    Phone
    +49 2543 21820
    Fax
    +49 2543 2182150
    E-mail
    info@medskin-suwelack.com
    Social
    • Facebook
    • Instagram
    • Twitter
    • LinkedIn
    Medskin Suwelack Copyright 2023
    • Contact
    • Imprint
    • Data Protection
    • GTC
    • GTP
    • Documents